Bristol-Myers Squibb Co (BMY)
48.92
+0.62
(+1.28%)
USD |
NYSE |
Apr 19, 16:00
48.90
-0.02
(-0.04%)
After-Hours: 20:00
Bristol-Myers Squibb Cash from Investing (TTM): -2.295B for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.295B |
| September 30, 2023 | 264.00M |
| June 30, 2023 | -1.407B |
| March 31, 2023 | -1.367B |
| December 31, 2022 | -1.062B |
| September 30, 2022 | -1.874B |
| June 30, 2022 | -769.00M |
| March 31, 2022 | -300.00M |
| December 31, 2021 | -538.00M |
| September 30, 2021 | -12.75B |
| June 30, 2021 | -11.99B |
| March 31, 2021 | -11.61B |
| December 31, 2020 | -10.86B |
| September 30, 2020 | -11.23B |
| June 30, 2020 | -10.52B |
| March 31, 2020 | -10.36B |
| December 31, 2019 | -9.913B |
| September 30, 2019 | 804.00M |
| June 30, 2019 | 166.00M |
| March 31, 2019 | -897.00M |
| December 31, 2018 | -2.00B |
| September 30, 2018 | 481.00M |
| June 30, 2018 | 770.00M |
| March 31, 2018 | 94.00M |
| December 31, 2017 | -66.00M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.069B |
| June 30, 2017 | -1.579B |
| March 31, 2017 | -149.00M |
| December 31, 2016 | 1.48B |
| September 30, 2016 | 480.00M |
| June 30, 2016 | 786.00M |
| March 31, 2016 | -900.00M |
| December 31, 2015 | -1.572B |
| September 30, 2015 | -237.00M |
| June 30, 2015 | -11.00M |
| March 31, 2015 | -242.00M |
| December 31, 2014 | 1.216B |
| September 30, 2014 | 550.00M |
| June 30, 2014 | -89.00M |
| March 31, 2014 | 1.479B |
| December 31, 2013 | -572.00M |
| September 30, 2013 | 20.00M |
| June 30, 2013 | -3.708B |
| March 31, 2013 | -3.539B |
| December 31, 2012 | -6.727B |
| September 30, 2012 | -6.509B |
| June 30, 2012 | -2.469B |
| March 31, 2012 | -3.027B |
| December 31, 2011 | -1.437B |
| September 30, 2011 | -4.411B |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-12.75B
Minimum
Sep 2021
804.00M
Maximum
Sep 2019
-5.137B
Average
-1.874B
Median
Sep 2022
Cash from Investing (TTM) Benchmarks
| Amgen Inc | -26.20B |
| Gilead Sciences Inc | -2.265B |
| Johnson & Johnson | 878.00M |
| Karuna Therapeutics Inc (DELISTED) | -160.32M |
| 2seventy bio Inc | 43.86M |